AGP Executive Report
Last update: 10 hours agoSuicide & justice in Iceland: In a new Sjónvarp Símans Premium true-crime interview, Ming Ting Mancel says she “couldn’t kill myself” and asked her husband to do it; she was sentenced to 12 years for killing her daughter at Reykjavík’s Edition hotel in June 2025, with the case framed around a plan to die together. Cardiometabolic health in Europe (incl. Iceland): JACARDI, a major EU4Health-backed joint action involving 18 EU countries plus Norway, Iceland and Ukraine, is pushing earlier prevention and better reach for cardiovascular disease and diabetes care. Rare disease treatment: The European Commission granted marketing authorisation for Nezglyal (leriglitazone) for early intervention in male childhood cerebral adrenoleukodystrophy (cALD), the first pharmacological option approved in the EU for this stage. Environmental health concern: Iceland toxicologist Oddný Ragnarsdóttir highlights PFAS “forever chemicals” as a possible skin exposure route, linking concerns to immune, liver and metabolic health. Diabetes research: A Norway study presented at EASD reports an 11% rise in type 1 diabetes incidence in young children after rotavirus vaccine rollout, while secondary analyses suggest the vaccine likely isn’t the cause. MS support: Oculis is partnering with the National Multiple Sclerosis Society to back its Campaign to End MS, focusing on vision and accelerating research and access to care. Public health safety: Nunavut health officials report suspected avian flu in 27 harvested birds near Iqaluit and stress basic food and handling precautions.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.